Tag Archives: vaccine

Oracle Helps NIH Build Cloud-Based Clinical Trial Registry

health IT

Oracle has built a cloud application system for a National Institutes of Health component to identify qualified participants for large-scale clinical trials of vaccines and monoclonal antibody therapies for the novel coronavirus. The registry is designed to screen indviduals who have volunteered to join tests through the National Institutes of Allergy and Infectious Diseases' COVID-19 Prevention Network, Oracle said Thursday.

Read More »

CSRA Subsidary’s Plague Vaccine Receives FDA Orphan Drug Designation

A plague vaccine being developed by a CSRA subsidiary has received orphan drug status from the U.S. Food and Drug Administration as a treatment for pre-exposure prophlaxis of Yersinia pestis infection. CSRA said Wednesday its DynPort Vaccine Company works with the Defense Department on the development of the recombinant rF1V plague vaccine that will be added …

Read More »

Engility Lands Army Task Order for Chikungunya Vaccine Clinical Trials; Lynn Dugle Comments

The Walter Reed Army Institute of Research has awarded Engility a potential five-year, $10 million task order to perform clinical trials of experimental vaccines against Chikungunya virus. Engility said Thursday it received the task order under a potential four-year, $900 million indefinite-delivery/indefinite-quantity contract awarded by the U.S. Army in January. …

Read More »

HHS to Fund Commercial Manufacturing Tests for BioProtection Systems’ Ebola Vaccine

The U.S. Department of Health and Human Services has awarded BioProtection Systems a contract with $24.75 million in base funds to support commercial manufacturing tests of the company’s anti-Ebola vaccine. HHS said Tuesday said the tests will work to validate whether manufacturing processes created under a previous contract would produce enough V920 vaccines in the event of …

Read More »

NIH Awards Grant to SAB Biotherapeutics for Flu Treatment R&D

SAB Biotherapeutics has received a $1.42 million Small Business Innovation Research grant from the National Institutes of Health to fund the production and preclinical testing of an antibody the company designed to treat influenza. The company said Wednesday it teamed up with the University of South Dakota’s Sanford School of Medicine for the project under the …

Read More »

Army Tests Ebola Vaccine Candidate With Yisheng Biopharma’s PIKA Adjuvant in Mice

The U.S. Army has begun preclinical trials of its vaccine candidate against Ebola virus in combination with the PIKA adjuvant platform developed by China-based Yisheng Biopharma. Study results show that mice that received a combination of the Army Medical Research Institute of Infectious Diseases’ virus-like particle-based vaccine and Yisheng’s PIKA …

Read More »

US Army’s Biomedical Research Lab, Immuron Partner for Shigella Vaccine Development

Australia-based bioptechnology company Immuron has signed a partnership agreement with a U.S. Army-run biomedical research institute to research and develop a vaccine against shigella gram-negative bacteria that cause intestinal diseases. Immuron and the the Walter Reed Army Institute of Research aim to produce a shigella vaccine for potential government, military and commercial applications, the company said Thursday. …

Read More »

PPD Lands 2 Contracts for R&D, Vaccine Services to Army & BARDA

Pharmaceutical Product Development will provide research and development and vaccine services to the U.S. Army and the Biomedical Advanced Research and Development Authority as part of two new contracts. The company said Thursday it will support Army R&D activities that work toward force readiness, improved health outcomes and the delivery of high-quality medical and preventative …

Read More »

Crucell Holland, Bavarian Nordic to Develop Experimental Ebola Vaccine Regimen for HHS

Crucell Holland will move forward with work to develop experimental vaccine regimen for Ebola under a potential seven-year, $69 million contract with the preparedness and response unit of the Department of Health and Human Services. HHS said Monday the Netherlands-based pharmaceutical company will work with Denmark-based Bavarian Nordic to develop the Ad26.ZEBOV prime and MVA-BN-Filo boost …

Read More »

Pfenex, HHS Begin Clinical Studies for New Anthrax Vaccine; Robin Robinson Comments

Pfenex Inc. and the Department of Health and Human Services have begun  clinical research for a new anthrax vaccine under a 30-month, $15.9 million contract. The Biomedical Advanced Research and Development Authority will lead the project to develop the experimental vaccines Px563L and RPA563, which target the anthrax cell-binding protein, HHS said …

Read More »